Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phenotypic and Genotypic Characterization of Hereditary Angioedema in Saudi Arabia. | J Clin Immunol | 2023 | 36348183 | PubTator, text mining | PubMed |
| Plasma Extracellular Vesicle Serpin G1 and CD14 Levels are Associated with Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients Undergoing Femoral Endarterectomy. | Eur J Vasc Endovasc Surg | 2023 | 36334903 | PubTator, text mining | PubMed |
| Triazol-1-yl Benzamides Promote Anticoagulant Activity via Inhibition of Factor XIIa. | Cardiovasc Hematol Agents Med Chem | 2023 | 36321236 | PubTator, text mining | PubMed |
| Classification and Treatment of Angioedema without Wheals: A Spanish Delphi Consensus. | Am J Clin Dermatol | 2023 | 36310330 | PubTator, text mining | PubMed |
| Therapeutic regulation of complement activation in extracorporeal circuits and intravascular treatments with special reference to the alternative pathway amplification loop. | Immunol Rev | 2023 | 36258635 | PubTator, text mining | PubMed |
| Immunopathology of terminal complement activation and complement C5 blockade creating a pro-survival and organ-protective phenotype in trauma. | Br J Pharmacol | 2023 | 36251578 | PubTator, text mining | PubMed |
| Accommodation in allogeneic and xenogeneic organ transplantation: Prevalence, impact, and implications for monitoring and for therapeutics. | Hum Immunol | 2023 | 36244871 | PubTator, text mining | PubMed |
| Acquired Angioedema Acute Attack After Administration of the Moderna COVID-19 (mRNA-1273) Vaccine. | Arch Bronconeumol | 2023 | 36243635 | PubTator, text mining | PubMed |
| Vascular surgery patients with elevated neutrophil-to-lymphocyte ratios have downregulated neutrophil complement RNA expression. | Blood Adv | 2023 | 36006440 | PubTator, text mining | PubMed |
| Epigenetic and integrative cross-omics analyses of cerebral white matter hyperintensities on MRI. | Brain | 2023 | 35943854 | PubTator, text mining | PubMed |
| Evaluation of C4b as an adjunct marker in symptomatic RT-PCR negative Covid-19 cases. | Indian J Clin Biochem | 2023 | 35756690 | PubTator, text mining | PubMed |
| Anesthetic management of a patient with acquired angioedema submitted to broncofibroscopy: a case report. | Braz J Anesthesiol | 2023 | 34848320 | PubTator, text mining | PubMed |
| Angiotensin-Converting Enzyme Inhibitor-Induced Non-allergic Perioral Angioedema: A Case-Based Scoping Review. | Korean J Fam Med | 2023 | 34808742 | PubTator, text mining | PubMed |
| MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. | Cell Biol Toxicol | 2023 | 34581912 | PubTator, text mining | PubMed |
| A Potentially Fatal Outcome of Oral Contraceptive Therapy: Estrogen-Triggered Hereditary Angioedema in an Adolescent | J Clin Res Pediatr Endocrinol | 2023 | 34565130 | PubTator, text mining | PubMed |
| Applications and continued evolution of glycan imaging mass spectrometry. | Mass Spectrom Rev | 2023 | 34392557 | PubTator, text mining | PubMed |
| C1 esterase inhibitor-mediated immunosuppression in COVID-19: Friend or foe? | Clin Immunol Commun | 2022 | 38013973 | PubTator, text mining | PubMed |
| Site-specific genome editing in treatment of inherited diseases: possibility, progress, and perspectives. | Med Rev (2021) | 2022 | 37724161 | PubTator, text mining | PubMed |
| Dysregulation of complement system in neuropsychiatric disorders: A mini review. | Biomark Neuropsychiatry | 2022 | 37123465 | PubTator, text mining | PubMed |
| Open-label Non-blinded Cohort study on Anti-Histaminic Resistant Chronic Idiopathic Urticaria in Western India. | Indian J Dermatol | 2022 | 36865849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=36